The role of ablative therapy for primary and oligometastatic renal cell carcinoma
Ablation therapy is emerging as a compelling alternate approach for the management of patients with renal cell carcinoma (RCC), particularly patients who are not surgical candidates. These treatment modalities provide an excellent local control and minimal toxicity, with potential to delay systemic...
Gespeichert in:
Veröffentlicht in: | Kidney cancer 2024, Vol.8 (1), p.187-192 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Review |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!